Stockscreener 앱 받기
5.99
0.00%
0.00
시간 외 거래:
5.99
Kamada Ltd 주식(KMDA)의 최신 뉴스
Kamada to Present at Stifel Healthcare Conference - TipRanks
Kamada to Present at the Stifel 2024 Healthcare Conference - GlobeNewswire
Earnings growth outpaced the 24% return delivered to Kamada (TLV:KMDA) shareholders over the last year - Simply Wall St
Blood Plasma Market to Grow by USD 15.9 Billion (2024-2028) as Innovative Solutions Address Global Blood Shortage; Report Highlights AI's Impact on Market TrendsTechnavio - The Malaysian Reserve
Global Healthcare & Medical Tourism News - Medical Tourism Magazine
Global Plasma Protein Therapeutics Market to Touch ~USD 40 Billion Mark by 2030 | DelveInsight - GlobeNewswire
What Jean-Philippe Mateta did after Daichi Kamada scored in Aston Villa 1-2 Crystal Palace, it was telling - We Are Palace
Kamada strike secures Quarter-Final spot - Holmesdale Online
Aston Villa 1-2 Crystal Palace: Daichi Kamada fires Eagles into last eight of Carabao Cupbut visitors lose - Daily Mail
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET - The Manila Times
Alvotech to Report Financial Results for the First Nine - GlobeNewswire
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19-20, 2024 - The Manila Times
Alvotech Meeting Investors and Presenting at the Jefferies - GlobeNewswire
Kamada (NASDAQ:KMDA) Shares Cross Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Kamada Ltd. Announces 2024 Annual General Meeting - TipRanks
Alpha 1 Lung Disease Market Projected to Reach $19.93 Billion by 2031 with 19.33% CAGR - WhaTech
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat
Lower Respiratory Tract Therapeutics Global Market Advancements Highlighted by Size, Insights Forecast, Tre... - WhaTech
Alpha 1 Antitrypsin Deficiency Treatment Market Size Is Booming Worldwide with Share, Size, Top Key Players - La Funcion mx
Japan's Daichi Kamada Confident in Chances of a World Cup Spot if They Beat Australia in Qualifiers - News18
Daichi Kamada says Japan can close in on World Cup place against Australia - Business Recorder
European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva® - The Manila Times
Kamada (NASDAQ:KMDA) Stock Crosses Below 200 Day Moving AverageShould You Sell? - MarketBeat
Equus Total Return And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Camtek Ltd. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
EastGroup Properties And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
What Oliver Glasner thinks of Daichi Kamada after slow start to life at Crystal Palace - We Are Palace
Plasma Therapy Market Advancements Highlighted by Size, Share Analysis And Forecast To 2033 - WhaTech
Lisandro Martinez is branded a 'coward' by former Premier League defender after escaping red card for 'unneces - Daily Mail
United States Genetic COPD Market Analysis By Size and Application - Third Eye News
Kamada Ltd expands plasma operations in Texas - Investing.com
Kamada Ltd expands plasma operations in Texas By Investing.com - Investing.com UK
Kamada Opens New Plasma Center in Houston - TipRanks
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston - GlobeNewswire
Kamada expands plasma collection operations in Texas - TipRanks
Kamada expands plasma collection operations in Texas with new site in Houston - Seeking Alpha
SASTRA signs MoU with Kaynes for semiconductor capacity building - Communications Today
Infra stock jumps 3% after receiving orders worth ₹ 1,003 Cr for multiple projects - Trade Brains
KEC International Boosts Market Presence with Rs 1,003 Crore New Contracts - PUNE.NEWS
India's KEC International rises on 10.03 bln rupee order wins - XM
KEC International shares surge 4% on new orders worth Rs 1,003 crore - Moneycontrol
KEC International has now won nearly 70% of the total orders it received in FY24 - CNBCTV18
Emphysema Treatment Market Innovations Investigated by Size, Share, Analysis, Trends 2024-2033 - WhaTech
'Give me my money', says Kedah winger Norde - New Straits Times
United States Alpha Antitrypsin Deficiency Treatment Market Analysis By Size and Application - Third Eye News
KDA FC Players Display ProfessionalismNafuzi - BERNAMA
Crystal Palace fans all saying the same thing about Daichi Kamada, they make one complaint - We Are Palace
Intravenous Immunoglobulin Global Market Size, Trends 2024-2033 - WhaTech
Kamada Ltd. (NASDAQ:KMDA) Shares Bought by Y.D. More Investments Ltd - MarketBeat
Kamada (NASDAQ:KMDA) Stock Price Passes Below 200-Day Moving Average of $5.50 - Defense World
Kamada (NASDAQ:KMDA) Shares Pass Below Two Hundred Day Moving Average of $5.50 - MarketBeat
Human Immunoglobulin Market to Grow by USD 9.69 Billion from 2024-2028, Driven by Increased Plasma Donations, Report Highlights AI's Role in Market TransformationTechnavio - The Malaysian Reserve
Human Immunoglobulin Market To Grow By USD 9.69 Billion From 2024-2028, Driven By Increased Plasma Donations, Report Highlights AI's Role In Market Tr... - MENAFN.COM
Immunoglobulins Market Innovations Investigated by Rising Trends, Key Leading Players, Trends Analysis, Ind... - WhaTech
Plasma Fractionation Global Market Innovations Investigated by Report 2024: Share and Size 2033 - WhaTech
Simulations Plus And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving Average of $5.53 - MarketBeat
What Daichi Kamada did in 39th minute of Chelsea 1-1 Crystal Palace to leave Oliver Glasner furious - We Are Palace
Eze's stunning strike earns Palace a point - Holmesdale Online
Alpha 1 Lung Disease Market to Surge at 19.33% CAGR, Reaching $19.93 Billion by 2031 - WhaTech
Kamada Ltd. (KMDA): A Cheap Pharmaceutical Stock to Buy According to Short Sellers - MSN
How To Trade (KMDA) - Stock Traders Daily
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Advancements Highlighted by Size, Share Analysis... - WhaTech
0.88%
0.42%
자본화:
|
볼륨(24시간):